Clinical Trials Directory

Trials / Completed

CompletedNCT00541827

Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients. Secondary aims are to clarify the pathogenesis and the clinical relevance of mitochondrial damage during sepsis.

Detailed description

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients, as compared to otherwise healthy surgical ones. In order to better clarify the pathogenesis of mitochondrial dysfunction during sepsis, cardiogenic shock patients (suffering from systemic hypoperfusion) will act as additional controls. Markers of oxidative stress will be measured in tissue samples from septic patients. The clinical relevance of mitochondrial dysfunction during sepsis will be assessed in terms of both skeletal muscle and platelet function.

Conditions

Timeline

Start date
2007-10-01
Primary completion
2011-08-01
Completion
2012-08-01
First posted
2007-10-10
Last updated
2013-09-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00541827. Inclusion in this directory is not an endorsement.